Opus Genetics licenses new preclinical program for inherited retinal disease Nov. 12, 2021 No Comments
Alu RNA induces retinal pigment epithelium degeneration in geographic atrophy via the inflammasome Oct. 21, 2021 No Comments
Atsena discloses preclinical gene therapy program for X-linked retinoschisis Oct. 19, 2021 No Comments
Preclinical studies show potential of melanocortin agonists PL-8331 and PL-9654 for ocular diseases Oct. 14, 2021 No Comments
SparingVision and Intellia Therapeutics establish strategic collaboration for ocular diseases Oct. 14, 2021 No Comments
Seed funding at Opus Genetics supports progression of programs in Leber congenital amaurosis Sep. 23, 2021 No Comments
RSS